Diagnostic performance of shear-wave dispersion imaging and shear-wave elastography for differentiating benign and malignant breast masses
摘要
Ultrasound advancements enable the automatic quantification of viscosity by measuring the dispersion slope of shear waves. This study evaluated the diagnostic performance of shear-wave dispersion imaging (SWD) in distinguishing benign from malignant breast masses and its supplementary role compared to shear-wave elastography (SWE).
Materials and methodsThis retrospective study included 630 pathologically confirmed breast lesions (395 benign, 235 malignant) in 604 women (mean age, 48 ± 11 years) from August 2020 to August 2021. Tumor elasticity (E_tumor) and the tumor-to-fat elasticity ratio (E_ratio) were measured using SWE, while tumor dispersion (D_tumor) and the tumor-to-fat dispersion ratio (D_ratio) were obtained using SWD. Diagnostic performance was evaluated using the AUC, with subgroup analyses based on lesion size, depth, and breast thickness.
ResultsD_tumor achieved the highest AUC (0.96 [95% CI: 0.95, 0.98]) compared with E_tumor (0.93 [95% CI: 0.91, 0.95]), E_ratio (0.92 [95% CI: 0.90, 0.94]), and D_ratio (0.95 [95% CI: 0.93, 0.96]) (p ≤ 0.003). D_tumor outperformed E_tumor for small lesions (≤ 10 mm and 11–20 mm: AUC 0.84 vs 0.67 and 0.91 vs 0.86, respectively; p ≤ 0.002) and BI-RADS 4B lesions (AUC 0.82 vs 0.70, p < 0.001). D_tumor maintained high performance across varying lesion depth and breast thickness, and it differentiated ductal carcinoma in situ from invasive carcinoma (p = 0.04), which SWE did not achieve.
ConclusionSWD improves the diagnostic performance across varying lesion size, depth, and breast thickness, addressing SWE’s limitations. It is particularly effective for small lesions (≤ 20 mm) and BI-RADS 4B masses.
Key Points